Danaher Corp (DHR.PR.A)

Overview

Danaher Corporation, established in 1969 and headquartered in Washington, D.C., is a globally recognized innovator and manufacturer of professional, medical, industrial, and commercial products and services. Originating as Diversified Mortgage Investors, Inc., the company underwent a name change to Danaher Corporation in 1984, marking the beginning of a new strategic direction. Over the years, Danaher has built a robust portfolio through the development and acquisition of products and services aimed at supporting the scientific, medical, and industrial communities. It maintains a strong commitment to research and development, highlighted by its collaboration with Stanford University's Department of Bioengineering focused on cancer drug development.

Products and Services

Danaher Corporation's offerings span multiple sectors, including Biotechnology, Life Sciences, and Diagnostics, through a range of well-regarded brands. Below is an overview of their primary products and services:

• Biotechnology: This segment underscores Danaher's role in advancing therapeutics' development and manufacturing. It includes bioprocess technologies, consumables, and services, cell line and cell culture media development, chromatography resins, filtration technologies, and aseptic fill finish solutions. Their offerings also comprise single-use hardware, consumables, and comprehensive services like manufacturing suite design and installation, alongside lab filtration, separation, purification products, reagents, membranes, and healthcare filtration solutions.
• Life Sciences: Here, Danaher offers instruments and consumables essential for research, discovery, and production processes in the life sciences. Key products include mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization tools. Additionally, the segment covers microscopes, protein consumables, industrial filtration products, and genomic medicines such as custom nucleic acids, plasmid DNA, RNA, and proteins. Renowned brand names within this segment include ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX.
• Diagnostics: Focused on enhancing diagnostic capabilities, this segment delivers an array of chemistry, immunoassay, microbiology, and automation systems. It caters to the needs of hospitals, physician offices, reference laboratories, and other critical care settings through products such as molecular, acute care, and pathology diagnostics, on top of clinical instruments, reagents, consumables, software, and services.